AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25039111 — intervention group
Group type: COMPARATOR
Intervention: Non-abused adolescents (control group)
Number of subjects: 84
Study 22952184 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 μg Se as l-selenomethionine)
Number of subjects: 255
Study 22952184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 22952184 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 255
Study 20724342 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose telmisartan (2 mg/kg/d)
Number of subjects: 77
Study 20724342 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose telmisartan (1 mg/kg/d)
Number of subjects: 77
Study 20724342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 18601636 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention via mail from community pharmacists, including educational material and encouragement to see a general practitioner for asthma management review.
Number of subjects: 1551
Study 18601636 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 1551
Study 16251800 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) on the first three and the last three schooldays every semester (group 2)
Number of subjects: 622
Study 16251800 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) on the first three schooldays every semester (group 1)
Number of subjects: 622
Study 16251800 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) on three consecutive days once a month during semesters (group 3)
Number of subjects: 622
Study 16251800 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinsing (FMR) once every fortnight during semesters (group 4)
Number of subjects: 622
Study 16251800 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rinsing)
Number of subjects: 622
Study 11872029 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital rectal examination (DRE) and transrectal ultrasonography (TRUS) as initial screening tests
Number of subjects: 117
Study 10091520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine-GITS (NIF, 30 mg/d)
Number of subjects: 12
Study 10091520 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ, 25 mg/d)
Number of subjects: 12
Study 10091520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine-GITS (NIF, 30 mg/d) + Hydrochlorothiazide (HCTZ, 25 mg/d)
Number of subjects: 12
Study 10091520 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 12
Study 7751519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine dihydrochloride 0.25 microgram/ml
Number of subjects: 40
Study 7751519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine dihydrochloride 1.0 and 2.5 micrograms/ml
Number of subjects: 40
Study 7751519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 and 20 mg/day
Number of subjects: 40
Study 7751519 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine therapy
Number of subjects: 40
Study 7751519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 1979241 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine b.i.d.
Number of subjects: 43
Study 1979241 — intervention group
Group type: COMPARATOR
Intervention: 60 mg terfenadine b.i.d. (Control)
Number of subjects: 43
Study 1979241 — intervention group
Group type: EXPERIMENTAL
Intervention: cetirizine
Number of subjects: 43
Study 6105244 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple mastectomy and routine immediate postoperative radiotherapy
Number of subjects: 0
Study 6105244 — intervention group
Group type: COMPARATOR
Intervention: Simple mastectomy alone (with radiotherapy later if disease recurred)
Number of subjects: 0
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: SonicFill (SF) with OptiBond FL (OFL, ER)
Number of subjects: 128
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk fill (TEC) with OptiBond FL (OFL, ER)
Number of subjects: 128
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: x‐tra fil (XF) with OptiBond FL (OFL, ER)
Number of subjects: 128
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: SonicFill (SF) with Xeno V+ (X, SE)
Number of subjects: 128
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram Bulk fill (TEC) with Xeno V+ (X, SE)
Number of subjects: 128
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: x‐tra fil (XF) with Xeno V+ (X, SE)
Number of subjects: 128
Study 30569286 — intervention group
Group type: COMPARATOR
Intervention: Incremental layering technique with Premise (P)
Number of subjects: 128
Study 30569286 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk-fill composites with Xeno V+ (X, SE)
Number of subjects: 128
Study 28914246 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP-ACP chewing gum
Number of subjects: 60
Study 28914246 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum
Number of subjects: 60
Study 26454838 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (2400mg total, 1200mg b.i.d.)
Number of subjects: 16
Study 26454838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 23695900 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonomotor treatment (60 hours over 6 weeks)
Number of subjects: 10
Study 21724087 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol II: toothbrushing + baseplate brushing + Periogard spraying on the seventh day after appliance placement
Number of subjects: 15
Study 21724087 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol III: toothbrushing + baseplate brushing + Periogard spraying on the fourth and seventh days after appliance placement
Number of subjects: 15
Study 21724087 — intervention group
Group type: COMPARATOR
Intervention: Protocol I: toothbrushing + baseplate brushing + sterile tap water spraying once a day
Number of subjects: 15
Study 21724087 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning electron microscope analysis
Number of subjects: 15
Study 19169143 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 M gadobutrol (0.1 mmol/kg body weight)
Number of subjects: 572
Study 19169143 — intervention group
Group type: COMPARATOR
Intervention: 0.5 M gadopentetate (0.1 mmol/kg body weight)
Number of subjects: 572
Study 19169143 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (1.0 M gadobutrol and 0.5 M gadopentetate)
Number of subjects: 572
Study 15678052 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy for 1 week (group A)
Number of subjects: 129
Study 15678052 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy for 3 weeks (group B)
Number of subjects: 129
Study 15678052 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiarrhythmic therapy for 6 weeks (group C)
Number of subjects: 129
Study 12707430 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine 225 mg
Number of subjects: 40
Study 12707430 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine 150 mg
Number of subjects: 40
Study 12707430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12707430 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine vs Imipramine
Number of subjects: 40
Study 12707430 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 40
Study 12707430 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 40
Study 10536913 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural interferon-beta (nIFN-beta) 6 MIU intramuscularly three times a week for 24 months
Number of subjects: 98
Study 10536913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 8916821 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose tranexamic acid (maximum of 20 g)
Number of subjects: 45
Study 8916821 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 1670840 — intervention group
Group type: EXPERIMENTAL
Intervention: calcipotriol ointment 50 micrograms/g
Number of subjects: 345
Study 1670840 — intervention group
Group type: COMPARATOR
Intervention: betamethasone valerate ointment 0.1%
Number of subjects: 345
Study 6226926 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin/mineral supplementation
Number of subjects: 20
Study 6226926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30924154 — intervention group
Group type: EXPERIMENTAL
Intervention: DSP-0565 administered orally to rats and dogs
Number of subjects: 0
Study 30924154 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro-in vivo extrapolation (IVIVE) with animal scaling factors
Number of subjects: 0
Study 30924154 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of scaling factors for hydrolysis pathway
Number of subjects: 0
Study 29916979 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice combined with speech therapy based on the Whole Language Model
Number of subjects: 32
Study 29916979 — intervention group
Group type: COMPARATOR
Intervention: Speech therapy based on the Whole Language Model (Control)
Number of subjects: 32
Study 26663215 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using methyl aminolaevulinate (MAL, 80 mg g(-1))
Number of subjects: 153
Study 26663215 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 153
Study 25102461 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium sulfate hemihydrate (Dentogen)
Number of subjects: 40
Study 25102461 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide cement (Dycal)
Number of subjects: 40
Study 22320349 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 µg subcutaneous injection)
Number of subjects: 0
Study 22320349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19848573 — intervention group
Group type: EXPERIMENTAL
Intervention: NovoFine 32-gauge tip 6mm needle
Number of subjects: 30
Study 19848573 — intervention group
Group type: COMPARATOR
Intervention: Micro Fine Plus 31-gauge 5mm needle
Number of subjects: 30
Study 17414741 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran 25 mg twice daily, then 50 mg twice daily until the 10th week
Number of subjects: 31
Study 17414741 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 31
Study 16263999 — intervention group
Group type: EXPERIMENTAL
Intervention: Heliox (70% helium, 30% oxygen) driven nebulized albuterol (15 mg/hour)
Number of subjects: 30
Study 16263999 — intervention group
Group type: COMPARATOR
Intervention: Oxygen (100% oxygen) driven nebulized albuterol (15 mg/hour)
Number of subjects: 30
Study 12537614 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice therapy intervention
Number of subjects: 0
Study 12537614 — intervention group
Group type: COMPARATOR
Intervention: Control period of observation
Number of subjects: 0
Study 9699783 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (early use)
Number of subjects: 0
Study 9699783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9699783 — intervention group
Group type: EXPERIMENTAL
Intervention: Different drugs or different doses of drug
Number of subjects: 0
Study 8729740 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN)
Number of subjects: 63
Study 8729740 — intervention group
Group type: COMPARATOR
Intervention: Glycerin (GL) placebo patches
Number of subjects: 63
Study 2172349 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium, 1% nasal solution, one spray per nostril, four times daily for 8 weeks
Number of subjects: 233
Study 2172349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cromolyn sodium, 4% nasal solution, one spray per nostril, four times daily for 8 weeks
Number of subjects: 233
Study 2172349 — intervention group
Group type: COMPARATOR
Intervention: Placebo, one spray per nostril, four times daily for 8 weeks
Number of subjects: 233
Study 361156 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 118
Study 361156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 31898511 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative hydroxyzine
Number of subjects: 188
Study 31898511 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure with placebo
Number of subjects: 188
Study 31898511 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard procedure with clowns
Number of subjects: 188
Study 31898511 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure with placebo and clowns
Number of subjects: 188
Study 29912307 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate switch to Dolutegravir (DTG-I)
Number of subjects: 415
Study 29912307 — intervention group
Group type: COMPARATOR
Intervention: Deferred switch to Dolutegravir (DTG-D)
Number of subjects: 415
Study 29912307 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DTG-I and DTG-D)
Number of subjects: 415
Study 25554858 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 250 mJ/4 Hz
Number of subjects: 12
Study 25554858 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser at 200 mJ/2 Hz
Number of subjects: 12
Study 25554858 — intervention group
Group type: COMPARATOR
Intervention: Control (zero cycles)
Number of subjects: 12
Study 23768444 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric Bypass (GB)
Number of subjects: 18
Study 23768444 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 18
Study 23768444 — intervention group
Group type: COMPARATOR
Intervention: Both GB and SG
Number of subjects: 18
Study 21639923 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (specific formula not detailed)
Number of subjects: 0
Study 21639923 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 19536163 — intervention group
Group type: EXPERIMENTAL
Intervention: High TAC diet (HT)
Number of subjects: 33
Study 19536163 — intervention group
Group type: COMPARATOR
Intervention: Low TAC diet (LT)
Number of subjects: 33
Study 16874594 — intervention group
Group type: EXPERIMENTAL
Intervention: Anorexic exercisers (AE)
Number of subjects: 7
Study 16874594 — intervention group
Group type: COMPARATOR
Intervention: Anorexic controls (AC)
Number of subjects: 7
Study 16874594 — intervention group
Group type: COMPARATOR
Intervention: Non-anorexic exercisers (NAE)
Number of subjects: 7
Study 14569412 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol with constant tube current-time settings (4 x 1-mm collimation, 120 kV, 400 mAs(eff))
Number of subjects: 50
Study 14569412 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually weight-adapted tube current-time settings
Number of subjects: 50
Study 10768804 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education program
Number of subjects: 9182
Study 8844923 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial services (more than 45 min)
Number of subjects: 3073
Study 8844923 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal behavioral and psychosocial factors (e.g., smoking, low weight for height, negative mood, rejection of pregnancy)
Number of subjects: 3073
Study 8844923 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial services
Number of subjects: 3073
Study 1727997 — intervention group
Group type: COMPARATOR
Intervention: Single dose of Curosurf (200 mg/kg)
Number of subjects: 343
Study 1727997 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of Curosurf (200 mg/kg initial dose + 2 additional doses of 100 mg/kg each)
Number of subjects: 343
Study 6091478 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g every 12 hours)
Number of subjects: 197
Study 6091478 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin (1 mg/kg every 8 hours) plus Clindamycin (8 mg/kg every 6 hours)
Number of subjects: 197
Study 30765629 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited resection for lung cancer
Number of subjects: 0
Study 30765629 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective lymph node dissection (SLND)
Number of subjects: 0
Study 30765629 — intervention group
Group type: COMPARATOR
Intervention: Radical segmentectomy
Number of subjects: 0
Study 30429438 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum, 2 pieces, 7 times/day for 2 days (n = 34)
Number of subjects: 70
Study 30429438 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chewing gum, n = 36)
Number of subjects: 70
Study 30429438 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol-containing chewing gum
Number of subjects: 70
Study 30429438 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 26856345 — intervention group
Group type: EXPERIMENTAL
Intervention: Patiromer
Number of subjects: 0
Study 24992147 — intervention group
Group type: EXPERIMENTAL
Intervention: Four translation strategies (educational materials, educational meetings, reminders, audit and feedback)
Number of subjects: 0
Study 21999476 — intervention group
Group type: EXPERIMENTAL
Intervention: Division of tongue-tie (Group A)
Number of subjects: 60
Study 21999476 — intervention group
Group type: COMPARATOR
Intervention: Non-division (Group B)
Number of subjects: 60
Study 20851080 — intervention group
Group type: EXPERIMENTAL
Intervention: LEISH-F1+MPL-SE vaccine (5, 10, or 20 μg recombinant Leishmania polyprotein LEISH-F1 antigen + 25 μg MPL(®)-SE adjuvant)
Number of subjects: 48
Study 20851080 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 48
Study 17611080 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of psychological treatment and anti-psychotic medication
Number of subjects: 41
Study 17611080 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy alone
Number of subjects: 41
Study 16372586 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan titrated to 40 mg
Number of subjects: 1855
Study 16372586 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan titrated to 80 mg
Number of subjects: 1855
Study 16372586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1855
Study 12789723 — intervention group
Group type: EXPERIMENTAL
Intervention: AK‐2123 (600 mg/m2 on alternate days)
Number of subjects: 98
Study 12789723 — intervention group
Group type: COMPARATOR
Intervention: Control (external radiation with telecobalt to a dose of 50 Gy and intracavitary radiation of 20 Gy)
Number of subjects: 98
Study 11518092 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (10 mg dose)
Number of subjects: 45
Study 11518092 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (higher doses)
Number of subjects: 45
Study 11518092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 9393912 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (6-week course)
Number of subjects: 107
Study 9393912 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 107
Study 7962318 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg hydrocortisone hemisuccinate
Number of subjects: 6
Study 7962318 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg hydrocortisone hemisuccinate
Number of subjects: 6
Study 7962318 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg hydrocortisone hemisuccinate
Number of subjects: 6
Study 7962318 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 6
Study 3296264 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyloroplasty
Number of subjects: 72
Study 3296264 — intervention group
Group type: COMPARATOR
Intervention: Control (nonuse of pyloroplasty)
Number of subjects: 72
Study 29484209 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbetocin
Number of subjects: 58
Study 29484209 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 58
Study 27343215 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-bundle (DB) ACL reconstruction with 6- to 8-stranded hamstring autograft
Number of subjects: 80
Study 27343215 — intervention group
Group type: COMPARATOR
Intervention: Single-bundle (SB) ACL reconstruction with 6- to 8-stranded hamstring autograft
Number of subjects: 80
Study 27343215 — intervention group
Group type: EXPERIMENTAL
Intervention: Both DB and SB ACL reconstruction
Number of subjects: 80
Study 26180363 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar stabilization exercise
Number of subjects: 30
Study 26180363 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 30
Study 23860935 — intervention group
Group type: EXPERIMENTAL
Intervention: Unidirectional barbed suture
Number of subjects: 50
Study 23860935 — intervention group
Group type: COMPARATOR
Intervention: Polyglactin 910 suture
Number of subjects: 50
Study 23860935 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 20626151 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 1907
Study 20626151 — intervention group
Group type: COMPARATOR
Intervention: Control groups (not specified)
Number of subjects: 1907
Study 19013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing aspartate aminotransferase (AST) level
Number of subjects: 176
Study 19013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing gamma-glutamyltransferase level
Number of subjects: 176
Study 19013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing AST level
Number of subjects: 176
Study 19013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing white blood cell count
Number of subjects: 176
Study 19013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing hematocrit
Number of subjects: 176
Study 19013463 — intervention group
Group type: EXPERIMENTAL
Intervention: Model with AST and alanine aminotransferase
Number of subjects: 176
Study 16815651 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen plus progestin (E+P)
Number of subjects: 16608
Study 16815651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16608
Study 12791621 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewing gum containing 1 mg nicotine and 0 mg caffeine
Number of subjects: 12